Literature DB >> 35552523

Cardiovascular disease risk factors and lifestyle modification strategies after pediatric kidney transplantation: what are we dealing with, and what can we target?

Se Ri Bae1, Alexandra Bicki2, Sarah Coufal3, Ethan Jin4, Elaine Ku5,3.   

Abstract

Kidney transplantation in pediatric patients can lead to partial improvement of some of the cardiometabolic parameters that increase the risk for cardiovascular disease (CVD) in patients with chronic kidney disease. However, even after restoration of kidney function, transplant recipients remain at risk for CVD due to the continual presence of traditional and non-traditional risk factors, including the side effects of immunosuppression and chronic inflammation. This educational review describes the prevalence of CVD risk factors in pediatric kidney transplant recipients and presents available evidence for therapeutic lifestyle changes and other non-pharmacologic strategies that can be used to improve traditional and modifiable CVD risk factors. Although trial-grade evidence for interventions that improve CVD in pediatric kidney transplant recipients is limited, potential strategies include lowering dietary sodium and saturated fat intake and increasing physical activity levels. Intensive follow-up may help patients achieve guideline-recommended goals for reducing their overall CVD risk.
© 2022. The Author(s), under exclusive licence to International Pediatric Nephrology Association.

Entities:  

Keywords:  Dyslipidemia; Hypertension; Kidney; Obesity; Pediatric; Transplant

Year:  2022        PMID: 35552523     DOI: 10.1007/s00467-022-05589-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  54 in total

1.  Change in mortality risk over time in young kidney transplant recipients.

Authors:  B J Foster; M Dahhou; X Zhang; R W Platt; J A Hanley
Journal:  Am J Transplant       Date:  2011-08-10       Impact factor: 8.086

Review 2.  Cardiovascular disease in children with chronic kidney disease.

Authors:  Mark M Mitsnefes
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

3.  KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients.

Authors:  Margaret Bia; Deborah B Adey; Roy D Bloom; Laurence Chan; Sanjay Kulkarni; Steven Tomlanovich
Journal:  Am J Kidney Dis       Date:  2010-07-02       Impact factor: 8.860

4.  Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association.

Authors:  Sarah D de Ferranti; Julia Steinberger; Rebecca Ameduri; Annette Baker; Holly Gooding; Aaron S Kelly; Michele Mietus-Snyder; Mark M Mitsnefes; Amy L Peterson; Julie St-Pierre; Elaine M Urbina; Justin P Zachariah; Ali N Zaidi
Journal:  Circulation       Date:  2019-03-26       Impact factor: 29.690

Review 5.  KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.

Authors:  Mark J Sarnak; Roy Bloom; Paul Muntner; Mahboob Rahman; Jeffrey M Saland; Peter W F Wilson; Linda Fried
Journal:  Am J Kidney Dis       Date:  2014-11-18       Impact factor: 8.860

Review 6.  Long-Term Survival after Kidney Transplantation.

Authors:  Sundaram Hariharan; Ajay K Israni; Gabriel Danovitch
Journal:  N Engl J Med       Date:  2021-08-19       Impact factor: 91.245

Review 7.  Hypertension and end-organ damage in pediatric renal transplantation.

Authors:  Mark M Mitsnefes
Journal:  Pediatr Transplant       Date:  2004-08

8.  Promoting cardiovascular health post-transplant through early diagnosis and adequate management of hypertension and dyslipidemia.

Authors:  Olga Charnaya; Michael Seifert
Journal:  Pediatr Transplant       Date:  2020-09-01

Review 9.  A Review of Pediatric Chronic Kidney Disease.

Authors:  C D W Kaspar; R Bholah; T E Bunchman
Journal:  Blood Purif       Date:  2016-01-15       Impact factor: 2.614

Review 10.  Management of dyslipidemia in pediatric renal transplant recipients.

Authors:  Margret E Bock; Leslie Wall; Carly Dobrec; Mary Chandran; Jens Goebel
Journal:  Pediatr Nephrol       Date:  2020-01-02       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.